Trial Profile
Fludarabine/Clofarabine/Busulfan combined with SAHA in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Jan 2022
Price :
$35
*
At a glance
- Drugs Vorinostat (Primary) ; Antithymocyte globulin; Busulfan; Clofarabine; Fludarabine
- Indications Acute myeloid leukaemia; Leukaemia; Myelodysplastic syndromes; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- Acronyms SAHA
- 15 Dec 2021 Status changed from active, no longer recruiting to completed.
- 29 Oct 2020 Planned primary completion date changed from 30 Mar 2020 to 30 Mar 2021.
- 10 May 2018 Status changed from recruiting to active, no longer recruiting.